Improving Thoracic Surgical Care Using Electronic Patient-Reported Outcomes (ePROS)

This is a single-site, non-randomized study on the outcomes of remote real-time "ePRO monitoring" in thoracic surgery patients. ePRO monitoring is a health information technology intervention comprised of delivering longitudinal electronic patient-reported outcome (ePRO) surveys (e.g., on symptoms, and physical functioning) coupled with automated provider alerts for concerning survey responses.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Thoracic surgery patients are at high risk for severe complications post-surgery, such as respiratory failure, empyema, wound problems, and even mortality. Patients with complications may need readmission and invasive management. Usual care may not capture the symptoms of surgery complications. Well-designed remote monitoring of postoperative patients may enable early intervention and lower the risk of severe complications.

This study evaluates the implementation and effectiveness of perioperative electronic patient-reported outcomes (ePROs) monitoring in thoracic surgery patients. Previous studies demonstrated the feasibility of ePROs monitoring by thoracic surgery patients and providers. This study will explore barriers to implementation before real-world effectiveness studies.

Study Type

Interventional

Enrollment (Estimated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • North Carolina
      • Chapel Hill, North Carolina, United States, 27599
        • Recruiting
        • Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill
        • Contact:
        • Contact:
          • MPH
        • Principal Investigator:
          • Gita Mody, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

Patients participating in ePRO monitoring must meet the following inclusion criteria to participate in this study:

  1. 18 years or older
  2. English or Spanish speaking
  3. Able to complete a web-based, telephonic (IVR), or CRA (or other IRB-approved research team member)-administrated symptom survey
  4. Planned to undergo major thoracic surgery (involving chest wall incisions and overnight admission)
  5. Discharged from the thoracic surgery service
  6. Discharged to home

Exclusion Criteria:

All patients meeting any of the following exclusion criteria at enrollment will be excluded from study participation:

  1. Not completing planned surgery within 3 months of obtaining informed consent
  2. Inability to understand English or Spanish
  3. Having undergone only minor thoracic surgery (e.g. bronchoscopy, cervical mediastinoscopy)
  4. Dementia, altered mental status, or any psychiatric condition determined by the thoracic surgery provider team that would prohibit the understanding or rendering of informed consent.
  5. Current incarceration
  6. Pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: ePRO monitoring
Thoracic surgery patients will be enrolled in ePRO monitoring using web-based or telephone surveys.
Alerts will be sent to providers via email and/or the electronic medical record at pre-specified response thresholds. Providers will be instructed to respond to and document the management of alerts per their clinical routine.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reach of ePRO monitoring
Time Frame: Months 4 through 6 after implementation of the study
Percentage of eligible thoracic surgery patients enrolling in ePRO monitoring.
Months 4 through 6 after implementation of the study
Adoption of ePRO monitoring
Time Frame: Months 4 through 6 after implementation of the study
Percentage of ePRO monitoring alerts sent that result in clinical action by providers within 1 week of delivery
Months 4 through 6 after implementation of the study
Patient-level Uptake
Time Frame: Months 4 through 6 after implementation of the study
the percentage of enrolled patients who participate in >=1 ePRO survey.
Months 4 through 6 after implementation of the study
Overall Reach of ePRO monitoring
Time Frame: End of study
Percentage of eligible thoracic surgery patients enrolling in ePRO monitoring.
End of study

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Complication Rate
Time Frame: Baseline through 30 days post-discharge
Percentage of participants with severe complications (Clavien-Dindo grade >=3)
Baseline through 30 days post-discharge
Emergency department visit at 30 days
Time Frame: Baseline through 30 days post-discharge
Percentage of participants with an emergency department visit
Baseline through 30 days post-discharge
Emergency department visit at 90 days
Time Frame: Baseline through 90 days post-discharge
Percentage of participants with an emergency department visit
Baseline through 90 days post-discharge
Readmission at 30 days
Time Frame: Baseline through 30 days post-discharge
Percentage participants readmitted to a hospital
Baseline through 30 days post-discharge
Readmission at 90 days
Time Frame: Baseline through 90 days post-discharge
Percentage participants readmitted to a hospital
Baseline through 90 days post-discharge
Mortality at 30 days
Time Frame: Baseline through 30 days
Percentage participants who died
Baseline through 30 days
Mortality at 90 days
Time Frame: Baseline through 90 days
Percentage participants who died
Baseline through 90 days
Patient Alert Rate
Time Frame: Baseline through 90 days
Percentage of all patients who trigger at least 1 alert.
Baseline through 90 days
Alert Rate
Time Frame: Baseline through 90 days
Percentage of all ePRO surveys that trigger an alert
Baseline through 90 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Gita Mody, MD, MPH, University of North Carolina, Chapel Hill

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 14, 2023

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Study Registration Dates

First Submitted

October 3, 2023

First Submitted That Met QC Criteria

October 3, 2023

First Posted (Actual)

October 10, 2023

Study Record Updates

Last Update Posted (Actual)

July 16, 2026

Last Update Submitted That Met QC Criteria

July 14, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

No plan as of now to make IPD available to other researchers.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe